November 16, 2024 at 12:42 PM
Looks like we need an update for this position statement to include #BlueSky
@bsky.app @mariajribal.bsky.social @giannarini.bsky.social @uroweb.bsky.social
#UroSoMe
@bsky.app @mariajribal.bsky.social @giannarini.bsky.social @uroweb.bsky.social
#UroSoMe
November 18, 2024 at 12:22 PM
Looks like we need an update for this position statement to include #BlueSky
@bsky.app @mariajribal.bsky.social @giannarini.bsky.social @uroweb.bsky.social
#UroSoMe
@bsky.app @mariajribal.bsky.social @giannarini.bsky.social @uroweb.bsky.social
#UroSoMe
Nice educational opportunity for physicians who diagnose/treat #ProstateCancer
Limited time only!
#radonc #UroSoMe #radiology
Limited time only!
#radonc #UroSoMe #radiology
🚨🚨Prostate and UREthra on MRI (PURE-MRI):
Try to contour (outline) the prostate and urethra on MRI for 1 patient
After everyone is done, we will enable the “answer key”
And you help us learn how to help doctors and AI do better
Sign up here: redcap.link/PURE-MRI
🙏🏼
Try to contour (outline) the prostate and urethra on MRI for 1 patient
After everyone is done, we will enable the “answer key”
And you help us learn how to help doctors and AI do better
Sign up here: redcap.link/PURE-MRI
🙏🏼
November 27, 2024 at 12:34 PM
Nice educational opportunity for physicians who diagnose/treat #ProstateCancer
Limited time only!
#radonc #UroSoMe #radiology
Limited time only!
#radonc #UroSoMe #radiology
Someone can explain to me how to creat your own environment as we used to have in the “other”place? #urosome #urology #ilooklikeaurologist #eauguidelines @uroweb.bsky.social
November 13, 2024 at 8:33 PM
Someone can explain to me how to creat your own environment as we used to have in the “other”place? #urosome #urology #ilooklikeaurologist #eauguidelines @uroweb.bsky.social
Editor's Choice of the Week: The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and MRI-targeted Biopsies are Discordant by @vickersbiostats.bsky.social et al in @eururolfocus.bsky.social
Read the full article here: buff.ly/4fS0sv9
#UroSoMe #EditorsChoice
Read the full article here: buff.ly/4fS0sv9
#UroSoMe #EditorsChoice
December 3, 2024 at 4:16 PM
Editor's Choice of the Week: The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and MRI-targeted Biopsies are Discordant by @vickersbiostats.bsky.social et al in @eururolfocus.bsky.social
Read the full article here: buff.ly/4fS0sv9
#UroSoMe #EditorsChoice
Read the full article here: buff.ly/4fS0sv9
#UroSoMe #EditorsChoice
European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 25.3 and over 2 million website downloads we are constantly striving to be a cut above the rest! Thank you to our Authors, Reviewers, and Readership!
#UroSoMe #EU #ImpactFactor
#UroSoMe #EU #ImpactFactor
November 19, 2024 at 1:36 PM
European Urology remains at the top of our field in Nephrology and Urology. With the new IF of 25.3 and over 2 million website downloads we are constantly striving to be a cut above the rest! Thank you to our Authors, Reviewers, and Readership!
#UroSoMe #EU #ImpactFactor
#UroSoMe #EU #ImpactFactor
We are extremely proud to announce that our 2023 IF is 8.3
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUO #ImpactFactor
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUO #ImpactFactor
November 19, 2024 at 1:28 PM
We are extremely proud to announce that our 2023 IF is 8.3
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUO #ImpactFactor
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUO #ImpactFactor
That’s a great question! For me, general shape and number of segments in the body and urosome.
December 4, 2024 at 12:38 PM
That’s a great question! For me, general shape and number of segments in the body and urosome.
Review: Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature Review from the European Association of Urology Patient Office by Carlotta Nedbal et al
Read the full review here: https://buff.ly/3ZeWEOr
#UroSky #UroSoMe
Read the full review here: https://buff.ly/3ZeWEOr
#UroSky #UroSoMe
November 22, 2024 at 9:29 AM
Review: Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature Review from the European Association of Urology Patient Office by Carlotta Nedbal et al
Read the full review here: https://buff.ly/3ZeWEOr
#UroSky #UroSoMe
Read the full review here: https://buff.ly/3ZeWEOr
#UroSky #UroSoMe
I am Jonathan Brisbon. I am a fourth year medical student from Rutgers RWJMS. I have applied to urology for residency .
I love everything fitness and basketball. I’m a cancer survivor. I love community health, surgical education, men’s health, and urological oncology.
#urosome #match2025
I love everything fitness and basketball. I’m a cancer survivor. I love community health, surgical education, men’s health, and urological oncology.
#urosome #match2025
November 9, 2024 at 2:23 AM
I am Jonathan Brisbon. I am a fourth year medical student from Rutgers RWJMS. I have applied to urology for residency .
I love everything fitness and basketball. I’m a cancer survivor. I love community health, surgical education, men’s health, and urological oncology.
#urosome #match2025
I love everything fitness and basketball. I’m a cancer survivor. I love community health, surgical education, men’s health, and urological oncology.
#urosome #match2025
Editorial: The Role of MSI/dMMR and TMB as Biomarkers in Predicting Immunotherapy Response in CRPC by Niklas Klümper et al
Read the full Editorial here: https://buff.ly/4ewXpH6
#ProstateCancer #ICIs #Biomarkers #CancerResearch #UroSky #UroSoMe #EU
Read the full Editorial here: https://buff.ly/4ewXpH6
#ProstateCancer #ICIs #Biomarkers #CancerResearch #UroSky #UroSoMe #EU
November 22, 2024 at 5:42 PM
Editorial: The Role of MSI/dMMR and TMB as Biomarkers in Predicting Immunotherapy Response in CRPC by Niklas Klümper et al
Read the full Editorial here: https://buff.ly/4ewXpH6
#ProstateCancer #ICIs #Biomarkers #CancerResearch #UroSky #UroSoMe #EU
Read the full Editorial here: https://buff.ly/4ewXpH6
#ProstateCancer #ICIs #Biomarkers #CancerResearch #UroSky #UroSoMe #EU
Good day to get started @Bluesky X was great for a long time and still not sure whether to leave it completely, but it's good to make a start here #Urology #UroSoMe
Fellow urologists! Please make an effort to bring the rest of us here.
For those in urology, this starter pack has all you need to keep things flowing in the Blue Zone!
#urology #urologylife
go.bsky.app/TSRtV3g
#urology #urologylife
go.bsky.app/TSRtV3g
November 15, 2024 at 11:40 PM
Words of Wisdom Wednesday: Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial by Stefano Mancon et al
Check out the summary below and read the full article here: https://buff.ly/4i9UNlJ
#UroSky #UroSoMe #EU #WoWWednesday
Check out the summary below and read the full article here: https://buff.ly/4i9UNlJ
#UroSky #UroSoMe #EU #WoWWednesday
November 20, 2024 at 5:42 PM
Words of Wisdom Wednesday: Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial by Stefano Mancon et al
Check out the summary below and read the full article here: https://buff.ly/4i9UNlJ
#UroSky #UroSoMe #EU #WoWWednesday
Check out the summary below and read the full article here: https://buff.ly/4i9UNlJ
#UroSky #UroSoMe #EU #WoWWednesday
We are extremely proud to announce that our 2023 IF is 3.2
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUROS #ImpactFactor
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUROS #ImpactFactor
November 19, 2024 at 1:52 PM
We are extremely proud to announce that our 2023 IF is 3.2
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUROS #ImpactFactor
We would like to sincerely thank all Authors, Reviewers, Readers, and Editorial Team!
#UroSoMe #EUROS #ImpactFactor
Editorial: Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer by Henning Plage et al
Full Editorial here: https://buff.ly/3ALyRfL
#UroSky #UroSoMe #EU
Full Editorial here: https://buff.ly/3ALyRfL
#UroSky #UroSoMe #EU
November 25, 2024 at 5:42 PM
Editorial: Patient-derived Models: A Promising Frontier in Testing the Efficacy of Drugs for Bladder Cancer by Henning Plage et al
Full Editorial here: https://buff.ly/3ALyRfL
#UroSky #UroSoMe #EU
Full Editorial here: https://buff.ly/3ALyRfL
#UroSky #UroSoMe #EU
Platinum Priority: Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response by N.M. Merrill et al
Full article: https://buff.ly/4i0cxQ7
Check back later for the editorial!
#UroSky #UroSoMe
Full article: https://buff.ly/4i0cxQ7
Check back later for the editorial!
#UroSky #UroSoMe
November 25, 2024 at 9:29 AM
Platinum Priority: Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response by N.M. Merrill et al
Full article: https://buff.ly/4i0cxQ7
Check back later for the editorial!
#UroSky #UroSoMe
Full article: https://buff.ly/4i0cxQ7
Check back later for the editorial!
#UroSky #UroSoMe
February 3, 2025 at 6:19 PM
Nice article about our new #UroSoMe home… I’m optimistic!
But can you believe there are only 20 people running this show #bluesky??
www.nytimes.com/2024/11/17/t...
But can you believe there are only 20 people running this show #bluesky??
www.nytimes.com/2024/11/17/t...
How Bluesky, Alternative to X and Facebook, Is Handling Growth
The fledgling social media site has been flooded with new users since the election. It hasn’t all been easy.
www.nytimes.com
November 19, 2024 at 2:43 AM
Nice article about our new #UroSoMe home… I’m optimistic!
But can you believe there are only 20 people running this show #bluesky??
www.nytimes.com/2024/11/17/t...
But can you believe there are only 20 people running this show #bluesky??
www.nytimes.com/2024/11/17/t...
#Coloplast is a proud sponsor of the Research on Calculus Kinetics society meeting. Our #Endourology team is looking forward to seeing you in Milwaukee, WI, January 31st - February 1st.
#ROCK25 #UroSoMe
#ROCK25 #UroSoMe
January 27, 2025 at 3:16 PM
#Coloplast is a proud sponsor of the Research on Calculus Kinetics society meeting. Our #Endourology team is looking forward to seeing you in Milwaukee, WI, January 31st - February 1st.
#ROCK25 #UroSoMe
#ROCK25 #UroSoMe
Join the next ERN eUROGEN webinar
🖥 Tissue Engineering as Applied to the Urinary Tract: Is it a Reality?
👤 Prof. Christopher R. Chapple
📅 Wednesday 28 May @ 18:00 CEST
🔗 bit.ly/eUROGEN28May25
#EUfunded #EU4Health #RareDisease #UroSoMe #Urology #FPMRS
🖥 Tissue Engineering as Applied to the Urinary Tract: Is it a Reality?
👤 Prof. Christopher R. Chapple
📅 Wednesday 28 May @ 18:00 CEST
🔗 bit.ly/eUROGEN28May25
#EUfunded #EU4Health #RareDisease #UroSoMe #Urology #FPMRS
May 26, 2025 at 6:01 AM
Join the next ERN eUROGEN webinar
🖥 Tissue Engineering as Applied to the Urinary Tract: Is it a Reality?
👤 Prof. Christopher R. Chapple
📅 Wednesday 28 May @ 18:00 CEST
🔗 bit.ly/eUROGEN28May25
#EUfunded #EU4Health #RareDisease #UroSoMe #Urology #FPMRS
🖥 Tissue Engineering as Applied to the Urinary Tract: Is it a Reality?
👤 Prof. Christopher R. Chapple
📅 Wednesday 28 May @ 18:00 CEST
🔗 bit.ly/eUROGEN28May25
#EUfunded #EU4Health #RareDisease #UroSoMe #Urology #FPMRS
Today I was invited to talk to an undergraduate class at Princeton University about cancer survivorship and its influence on me becoming a doctor. I love sharing my story! It’s one of the reasons why I’m pursuing urology #urosome
November 14, 2024 at 3:12 AM
Today I was invited to talk to an undergraduate class at Princeton University about cancer survivorship and its influence on me becoming a doctor. I love sharing my story! It’s one of the reasons why I’m pursuing urology #urosome
TONIGHT! Join an @erneurogen.bsky.social webinar supported by @espu.bsky.social:
🖥 Long-Term Outcomes in #Hypospadias
👥 Anne-Françoise Spinoit & Lloyd Tack
📅 Wednesday 19 February, 18:00 CET
🔗 https://buff.ly/3XnnPpd
#EUfunded #HealthUnion #EU4Health #UroSoMe #Urology #PedUro #SoMe4PedSurg
🖥 Long-Term Outcomes in #Hypospadias
👥 Anne-Françoise Spinoit & Lloyd Tack
📅 Wednesday 19 February, 18:00 CET
🔗 https://buff.ly/3XnnPpd
#EUfunded #HealthUnion #EU4Health #UroSoMe #Urology #PedUro #SoMe4PedSurg
All-in-one virtual event platform | Zoom Events
buff.ly
February 19, 2025 at 7:00 AM
TONIGHT! Join an @erneurogen.bsky.social webinar supported by @espu.bsky.social:
🖥 Long-Term Outcomes in #Hypospadias
👥 Anne-Françoise Spinoit & Lloyd Tack
📅 Wednesday 19 February, 18:00 CET
🔗 https://buff.ly/3XnnPpd
#EUfunded #HealthUnion #EU4Health #UroSoMe #Urology #PedUro #SoMe4PedSurg
🖥 Long-Term Outcomes in #Hypospadias
👥 Anne-Françoise Spinoit & Lloyd Tack
📅 Wednesday 19 February, 18:00 CET
🔗 https://buff.ly/3XnnPpd
#EUfunded #HealthUnion #EU4Health #UroSoMe #Urology #PedUro #SoMe4PedSurg
At #EAU25, John Osborne, ERN eUROGEN ePAG Chair, spoke on “Patient Power” 💪
Highlights: patients shape guidelines, care pathways & more. 2025 strategy = QoL & awareness.
🔗 Learn more: bit.ly/41ScgYl
#ePAG #RareDisease #UroSoMe #EUfunded
Highlights: patients shape guidelines, care pathways & more. 2025 strategy = QoL & awareness.
🔗 Learn more: bit.ly/41ScgYl
#ePAG #RareDisease #UroSoMe #EUfunded
March 24, 2025 at 9:00 AM
At #EAU25, John Osborne, ERN eUROGEN ePAG Chair, spoke on “Patient Power” 💪
Highlights: patients shape guidelines, care pathways & more. 2025 strategy = QoL & awareness.
🔗 Learn more: bit.ly/41ScgYl
#ePAG #RareDisease #UroSoMe #EUfunded
Highlights: patients shape guidelines, care pathways & more. 2025 strategy = QoL & awareness.
🔗 Learn more: bit.ly/41ScgYl
#ePAG #RareDisease #UroSoMe #EUfunded